Mayne Pharma Group Stock Price Down 4 percent - Defense World
| MAYNF Stock | USD 3.10 0.10 3.33% |
Roughly 55% of Mayne Pharma's stockholders are presently thinking to get in. The analysis of overall sentiment of trading Mayne Pharma Group pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Mayne Pharma's historical and current headlines, can help investors time the market. In addition, many technical investors use Mayne Pharma Group stock news signals to limit their universe of possible portfolio assets.
Mayne Pharma pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Mayne daily returns and investor perception about the current price of Mayne Pharma Group as well as its diversification or hedging effects on your existing portfolios.
Mayne |
Mayne Pharma Group Stock Price Down 4 Defense World
Read at news.google.com
 |
Mayne Pharma Fundamental Analysis
We analyze Mayne Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mayne Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mayne Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Mayne Pharma is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Mayne Pharma Group Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mayne Pharma pink sheet to make a market-neutral strategy. Peer analysis of Mayne Pharma could also be used in its relative valuation, which is a method of valuing Mayne Pharma by comparing valuation metrics with similar companies.
Peers
Mayne Pharma Related Equities
| MRK | Merck | 1.50 | ||||
| AMGN | Amgen | 0.24 | ||||
| GILD | Gilead Sciences | 0.04 | ||||
| BMY | Bristol Myers | 0.65 | ||||
| ABBV | AbbVie | 0.68 | ||||
| JNJ | Johnson Johnson | 1.74 |
Complementary Tools for Mayne Pink Sheet analysis
When running Mayne Pharma's price analysis, check to measure Mayne Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mayne Pharma is operating at the current time. Most of Mayne Pharma's value examination focuses on studying past and present price action to predict the probability of Mayne Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mayne Pharma's price. Additionally, you may evaluate how the addition of Mayne Pharma to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |